[google-translator]
Univdatos Whatsapp

Increasing demand for more accurate and effective models, and advancements in genetic engineering technologies has propelled the Growth of the Mice Model Market in the North America Region!

North America is a significant market for mice models, driven by the presence of many pharmaceutical and biotechnology companies involved in drug development. The region has a strong research infrastructure, with many universities and research institutions engaged in innovative research projects. The increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, has driven the demand for new drugs and therapies, fueling the growth of the mice model market.

Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=38377

Furthermore, the growing focus on personalized medicine has led to an increased demand for customized mice models that can simulate human diseases accurately. The high level of investment in research and development and technological advancements in mice model generation and breeding techniques has also contributed to the growth of the mice model market in North America.

Further, the North America mice model market is expected to grow at a strong CAGR of 6% during the forecast period (2022-2030) owing to the growing demand for personalized medicine. Personalized medicine aims to develop treatments that are tailored to an individual’s genetic makeup, and mice models are an essential tool in this process.

Mice Model Market

For a detailed analysis of the Global Mice Model Market browse through :- https://univdatos.com/report/mice-model-market/

By technology, the mice model market in North America can be segmented into CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, and others. CRISPR dominates the market owing to the high accuracy and efficiency of CRISPR-based gene editing techniques. Furthermore, the technological advancements in CRISPR gene editing techniques and the growing demand for humanized mice models are driving the growth of the genetic engineering segment. For instance, researchers at Cold Spring Harbor Laboratory used CRISPR/Cas9 technology in June 2019 to create mutations in the tomato flowering suppressor, which led to quick flowering, more compact development, and ultimately an early harvest.

By end user, the mice model market in North America can be segmented into academics institute & research centers, pharmaceutical & biotech companies, CROs and CMOs, and others. Pharmaceutical and biotechnology companies dominate the market in the region owing to the increasing demand for new drugs and therapies. Furthermore, the growing focus on personalized medicine and the rise in chronic diseases are driving the demand for mice models in drug discovery and development.

Global Mice Model Market Segmentation

Market Insight, by Mice Type

  • Inbred
  • Outbred
  • Knockout
  • Hybrid
  • Others

Market Insights, by Technology

  • CRISPR
  • Microinjection
  • Embryonic Stem Cell Injection
  • Nuclear Transfer
  • Others

Market Insights, by Aplication

·       Drug Discovery & Development

·       Research Centers

·       PDx Models/Xenograft

Market Insights, by End-Users

·       Academics Institute & Research Centers

·       Pharmaceutical & Biotech Companies

·       CROs and CMOs

·       Others

Market Insight, by Region

  • North America
    •  U.S.
    •  Canada
    •  Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • APAC
    • China
    • India
    • Japan
    • Rest of APAC
  • Rest of the World

Top Company Profiles

  • Envigo Marketing Private Limited
  • Laboratory Corporation of America® Holdings
  • Janvier Labs
  • Harbour Antibodies Bv
  • Charles River Laboratories
  • THE JACKSON LABORATORY
  • Taconic Biosciences, Inc.
  • genOway
  • Horizon Discovery Ltd., Company
  • ingenious targeting laboratory